http://www.twitter.comTwitter is a service for friends, family, and co-workers to communicate and stay connected through the exchange of quick, frequent answers to one simple question: What are you doing?
-
Mednow Achieves Record Q3 2023 Financial Results with Quarterly Revenue of $12.8 Million; 13% Q/Q Revenue Growth and 105% Y/Y Revenue Growth; Continues to Focus on Core Virtual Pharmacy Growth and Cos
-
Mednow to Host Quarterly Conference Call on Friday, June 30, 2023, at 8:30am EST on its Third-Quarter 2023 Financial Results
-
Mednow Announces Closing of Prospectus Supplement Financing Led by Gravitas Securities and Concurrent Non-brokered Private Placement for Aggregate Proceeds of $1.1 Million
-
Mednow Announces Filing of Prospectus Supplement
-
Mednow Announces Financing by Way of Prospectus Supplement for Proceeds of up to $1,000,000 Led by Gravitas Securities
-
Mednow announces PBAS partnership.
-
Mednow Achieves Record Q2 2023 Financial Results with Quarterly Revenue of $11.3 Million; 17% Q/Q Revenue Growth and 466% Y/Y Revenue Growth; Adjusted EBITDA Improved 32% Y/Y; and Cash Flow from Opera
-
Mednow to Host Quarterly Conference Call on Friday, March 31, 2023, at 8:30am EST on its Second-Quarter 2023 Financial Results
-
Mednow Launches New Virtual Diabetes Management Program in Partnership With Dexcom
-
Mednow Achieves Record Q1 2023 Financial Results with Quarterly Revenue of $9.7 Million; 35% Q/Q Revenue Growth and 1,300% Y/Y Revenue Growth; Costs Down 30% and Cash Flow from Operations Improved by
-
Mednow to Host Quarterly Conference Call on Wednesday January 18, 2023, at 8:30am EST on its First-Quarter 2023 Financial Results
-
Mednow Announces Filing of Application for Management Cease Trade Order and Change of Auditor
-
Mednow Achieves Record Q4 2022 Financial Results with +11% Q/Q Revenue Growth and 5,700% Y/Y Revenue Growth
-
Mednow to Host Quarterly Conference Call on Tuesday November 29, 2022, at 8:30am EST on its Fourth-Quarter 2022 Financial Results
-
Mednow Announces Senior Secured Convertible Debenture Financing of up to $3,000,000 Led by Gravitas Securities
-
Mednow to Present at the H.C. Wainwright 24th Annual Global Investment Conference
-
Mednow’s Liver Care Canada Partners With HepCURE With the Goal of Eliminating Hepatitis C in Canada by 2030
-
Mednow Beats Guidance & Achieves Record Q3 2022 Financial Results with 225% Q/Q Revenue Growth and 4,800% Y/Y Revenue Growth and Appoints Ali Reyhany CEO
-
Mednow to Present at Gravitas’ 3rd Los Angeles Summit
-
Mednow Announces the Graduation to OTCQX Trading, to Expand Access to U.S. Investors
-
Mednow Provides Revenue Guidance on Fiscal Q3 2022, a Projected Record C$5 - C$5.5 Million in Quarterly Revenue, Q/Q Growth of Approx. 175%
-
Mednow Launches Personalized Supplement Program
-
Mednow Named Great Place to Work® 2022 Best Workplaces For Women
-
Mednow Enters Into Agreement to Acquire Mednow East Inc. in Ontario
-
Mednow Acquires the License and Exclusive Canadian Distribution Rights for Genetic Testing Technology from TruDiagnostic™
-
Mednow Closes Previously Announced Acquisition of Pharmacy in British Columbia
-
Mednow Enters Into Agreement to Acquire a Pharmacy in British Columbia
-
Mednow to Present at the Virtual Gravitas Health Reimagined Investor Day
-
Mednow Commences Operation in Nova Scotia
-
Mednow Acquires Medvisit, Canada’s Largest and Longest Standing Doctor Home Visit Provider
-
Mednow Invests in Life Support Mental Health Inc. and Signs Non-Binding Letter of Intent to Acquire Complementary Medical Operation
-
Mednow Receives DTC Eligibility and Amends Stock Option Plan
